Cuidados generales y tratamiento de la hemofilia

[vc_row][vc_column][vc_column_text css=”.vc_custom_1469063078077{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 10px !important;}”]This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of Hemophilia. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life an introduction to hemophilia and the WFH recommendations regarding principles of care, comprehensive care, […]
Soins généraux et prise en charge de l'hémophilie

[vc_row][vc_column][vc_column_text css=”.vc_custom_1469063356286{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 10px !important;}”]This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of Hemophilia. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life an introduction to hemophilia and the WFH recommendations regarding principles of care, comprehensive care, […]
Desmopressin (DDAVP)

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than […]
Desmopressin (DDAVP)

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than […]
Desmopressin (DDAVP)

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than […]
Desmopressin (DDAVP)

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may be the treatment of choice for patients with mild or moderate hemophilia A and type 1 von Willebrand disease (VWD). This Fact Sheet presents essential information about this synthetic medicine which costs much less than […]
Fibrinolytic Inhibitors in the Management of Bleeding Disorders

A description of the mechanism of action of fibrinolytic inhibitors and their use in the treatment of inherited bleeding disorders including hemophilia A and B, von Willebrand disease, and platelet disorders.
Joint Replacement Surgery in Hemophilia

A comprehensive, multidisciplinary overview of the key issues in joint replacement surgery, from pre-operative assessment to long-term management.
Articular Bleeding (Hemarthrosis) in Hemophilia: An Orthopedist's Point of View

Strategies for the prevention and proper management of acute, subacute, and recurrent hemarthrosis.
Chronic Hemophilic Synovitis: The Role of Radiosynovectomy

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Japanese Reviews the pathogenesis of chronic hemophilic synovitis, its clinical characteristics, and therapeutic options, with special emphasis on radiosynovectomy performed with 32P-chromic phosphate.